The DOI matches its Crossref record.
Detection of activity of P‐glycoprotein in human tumour samples using rhodamine 123
Abstract
Summary Based on the fluorescent properties of the dye rhodamine 123 (Rh123), which is transported by the membrane efflux pump P‐glycoprotein (P‐gp), we developed a functional flow cytometric assay for the detection of multidrug‐resistant (MDR) cells. Using drug sensitive cell lines (KB‐3–1) and MDR mutants (KB‐8–5, KB‐C1) experimental conditions were established that enabled demonstration of significant differences in Rhl23 efflux and accumulation. Subsequently we investigated the applicability of this functional assay for the prediction of MDR in human peripheral blood and bone marrow samples. Using two‐colour flow cytometry, the leukaemic blast cells of six patients suffering from acute myeloid leukaemia (AML) were analysed. In three cases the blast cells showed a rapid and marked Rh123 efflux. In the presence of MDR inhibitors these cells retained Rh123. To determine whether the efflux of Rhl23 was associated with P‐gp expression, the leukaemic cells were stained with the monoclonal antibody MRK‐16. In addition extracted RNA was analysed by polymerase chain reaction to evaluate the expression of mdr 1 mRNA. In all three Rh123+ cases mdr 1 mRNA was detectable whereas only one AML case expressed P‐gp. In comparing Rh123 with daunorubicin, which also allows the detection of MDR cells, accumulation studies proved Rh123 to be the more sensitive drug for flow cytometric MDR screening. Additionally, two‐colour flow cytometry was much easier to perform with Rh123 than with daunorubicin. Our results indicate that flow cytometric measurement of Rh123 accumulation/efflux proves applicable to detect MDR cells in heterogenous clinical samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ramesh, R., Kozhaya, L., McKevitt, K., Djuretic, I. M., Carlson, T. J., Quintero, M. A., McCauley, J. L., Abreu, M. T., Unutmaz, D., & Sundrud, M. S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130301 · Cited by 440
Scambia, G., Ranelletti, F. O., Panici, P. B., De Vincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685655 · Cited by 271
The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids
Cao, W., Kayama, H., Chen, M. L., Delmas, A., Sun, A., Kim, S. Y., Rangarajan, E. S., McKevitt, K., Beck, A. P., Jackson, C. B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.012 · Cited by 102
Lin, H.-L., Liu, T.-Y., Wu, C.-W., & Chi, C.-W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690710 · Cited by 100
Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer
Lima, T. S., Souza, L. O., Iglesias-Gato, D., Elversang, J., Jørgensen, F. S., Kallunki, T., Røder, M. A., Brasso, K., & Moreira, J. M. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.869461 · Cited by 26
Metadata
- Authors
- Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., And, H. H., & Hofmann, J.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1992-09
- Volume
- 82
- Issue
- 1
- Pages
- 161-168
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2009098269
- Cited by
- 169
- References
- 0
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detection of activity of P‐glycoprotein in human tumour samples using rhodamine 123. https://app.cochat.ai/papers/10.1111/j.1365-2141.1992.tb04608.x
- The paper
- Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., And, H. H., & Hofmann, J. (1992). Detection of activity of P‐glycoprotein in human tumour samples using rhodamine 123. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1992.tb04608.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.